RxDoctor Payments Data

Manju Schorr

Endocrinology, Diabetes & Metabolism · Yuma, AZNPI 1972676344

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $19,455 of the $24,244 with a category attached, or 80.2%. 13 manufacturers reported payments, led by Johnson & Johnson at 38.7% of the total. Reporting peaked in 2019 at $19,857 and has fallen 99.4% since, to $125 in 2021.

$24,244in general payments, 2019–2025

Across 190 payments — averaging $127.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$9K
  • AstraZeneca$8K
  • AbbVie$5K
  • Novo Nordisk$488
  • Sanofi-aventis U.S. LLC$463
  • Janssen Scientific Affairs, LLC$161
  • plus $334 from 7 others

What the payments were for

  • Speaking & faculty fees$19,45580%
  • Travel & lodging$6873%
  • Food & beverage$4,07717%
  • Education$250%

General payments by program year

19
20
21

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$24,244 in reported general payments places this provider in the 85th percentile of 148 endocrinology, diabetes & metabolism providers in Arizona.

See all endocrinology, diabetes & metabolism providers in Arizona

Other endocrinology, diabetes & metabolism in Yuma

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →